Publications

Alizada S, Eldaya RW, Salim HA, Taslicay CA, Gubbiotti MA, De B, Weathers SP, Wintermark M, Al Qudah H. Clinical and Imaging Features of Primary Intradural Extramedullary Ewing Sarcoma. AJNR Am J Neuroradiol. 2025 Dec 4;46(12):2697-2704. doi: 10.3174/ajnr.A8872. PMID: 40506234; PMCID: PMC12687948.

Amer A, Ansari S, Krayyem A, Kundu S, Khose S, Pokhylevych H, Calle S, Patel CB, Yang Z, Liu HA, Johnson JM. Dynamic Contrast-enhanced MRI Processing Comparison for Distinguishing True Progression From Pseudoprogression in High-grade Glioma. J Comput Assist Tomogr. 2025 Jul-Aug 01;49(4):656-661. doi: 10.1097/RCT.0000000000001716. Epub 2025 Jan 27. PMID: 39876523; PMCID: PMC12237096.

Bejugam D, Peck KK, Saha A, Yllera-Contreras E, Yildirim O, Arevalo-Perez J, Krebs SS, Lis E, Karimi S, Holodny AI. Detection of Osseous Spinal Metastasis with T1-Weighted Dynamic Contrast-Enhanced MRI and 18F-FDG PET/CT: Assessing Agreement in Biopsy Proven Cases. AJNR Am J Neuroradiol. 2026 Jan 22:ajnr.A9181. doi: 10.3174/ajnr.A9181. Epub ahead of print. PMID: 41571404.

Chang MC, Malut VR, Mahar R, Rushin A, McLeod MA, Pierre GL, Malut IR, Staklinski SJ, Glanz ME, Ragavan M, Sharma G, Madheswaran M, Badar A, Rao AD, Law BK, Kilberg MS, Collins JHP, Kodibagkar VD, Bankson JA, DeBerardinis RJ, Merritt ME. Assessing cancer therapeutic efficacy in vivo using [2H7]glucose deuterium metabolic imaging. Sci Adv. 2025 Mar 28;11(13):eadr0568. doi: 10.1126/sciadv.adr0568. Epub 2025 Mar 26. PMID: 40138413; PMCID: PMC11939044.

Dagher SA, Alizada S, Al Qudah H, Waguespack SG, Shah KB, Eldaya RW. Imaging and clinical course of metastatic pituitary neuroendocrine tumors (PitNET): A single center case series. Neuroradiol J. 2025 Jun 27:19714009251356278. doi: 10.1177/19714009251356278. Epub ahead of print. PMID: 40576016; PMCID: PMC12204987.

Dagher SA, Johnson JM, Mohamed RMM, Ansari S, Mawlawi O, Liu HL, Wintermark M, Schellingerhout D, Flynt L, Yeboa DN, Weinberg JS, Ferguson SD, Gule-Monroe MK. Study of 18 F-fluciclovine PET for serial assessment of glioblastoma tumor volumes during surgery and radiotherapy. J Neurooncol. 2025 Nov;175(2):549-560. doi: 10.1007/s11060-025-05146-2. Epub 2025 Jul 1. PMID: 40591209; PMCID: PMC12420720.

Eldaya RW, Kaya D, Williams M, Calle S, Schellingerhout D. Clinical and Imaging Features of Head and Neck Metastasis of High-Grade Glioma: A Single-Center Case Series. AJNR Am J Neuroradiol. 2025 Jan 8;46(1):160-165. doi: 10.3174/ajnr.A8521. PMID: 39667825; PMCID: PMC11735445.

Gajecki L, Lebedeva IV, Liao YR, Ambriz D, Carter LM, Kumpf M, Lovibond S, Hachey JS, Graham MS, Postow M, Lewis JS, Andrew DP, Baca M, Schöder H, Larson SM, Veach DR, Krebs S. IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies. J Nucl Med. 2025 Apr 1;66(4):605-611. doi: 10.2967/jnumed.124.268762. PMID: 39978817; PMCID: PMC11960613.

Gule-Monroe M, Chasen N, Long JP, Kumar VA, Shah K, Chen M, Stafford J, Chung C, Wintermark M, Hou P, Sura E, Wang C, Weinberg J, Liu HL. Diagnostic Confidence of Contrast-Enhanced T1-Weighted MRI for the Detection of Brain Metastases: 3D FSE versus 3D GRE-Based Sequences. AJNR Am J Neuroradiol. 2025 Jun 3;46(6):1231-1237. doi: 10.3174/ajnr.A8590. PMID: 39572196; PMCID: PMC12152807.

Kaffey Z, Mirbahaeddin S, Wahid K, Kamel S, Vouffo M, Otun AO, Belal Z, Aponte Wesson RA, Carriere PP, Dede C, Maniakas A, Goepfert RP, Garden AS, Lee A, Choi KY, Christensen JM, Lincoln C, Manzar GS, Dudzinski SO, Thomas R, Mehrens H, Cardoso RC, Schellingerhout D, Watson E, Chen MM, Lai SY, Fuller CD, Moreno AC, Humbert-Vidan L; MD Anderson Head and Neck Cancer Symptom Working Group. Radiographic classification of mandibular osteoradionecrosis: A blinded prospective multi-disciplinary interobserver diagnostic performance study. Radiother Oncol. 2025 Jul;208:110917. doi: 10.1016/j.radonc.2025.110917. Epub 2025 May 2. PMID: 40320174; PMCID: PMC12158629.

Kamel PI, Doo FX, Savani D, Kanhere A, Yi PH, Parekh VS. Standardizing Heterogeneous MRI Series Description Metadata Using Large Language Models. J Imaging Inform Med. 2026 Feb;39(1):962-972. doi: 10.1007/s10278-025-01541-3. Epub 2025 May 29. PMID: 40442564; PMCID: PMC12921075.

Krebs S, Baird L, Pirovano G, Yamaguchi A, Coll RP, Lee JT, Carroll LS, Pomper MG, Manning HC. Today's Research, Tomorrow's Practice - White Paper from the Translation of New Therapy (TNT) Radiotheranostics Kick-off Pre-meeting of the Annual World Molecular Imaging Conference 2024. Mol Imaging Biol. 2025 Dec;27(6):877-882. doi: 10.1007/s11307-025-02054-9. Epub 2025 Sep 19. PMID: 40971127.

Lam K, Ozkizilkaya HI, Milton DR, Dono A, Liu Y, Kundu S, Kumar VA, Johnson JM, Esquenazi Y, Patel CB, Ballester LY. Molecular alterations in IDH-mutant astrocytoma: A multi-institutional retrospective study. Neurooncol Adv. 2025 Apr 28;7(1):vdaf088. doi: 10.1093/noajnl/vdaf088. PMID: 40575414; PMCID: PMC12199353.

Michel KA, Harlan CJ, Walker CM, Merritt ME, Chen Y, Lai SY, Bankson JA. Pharmacokinetic modeling strategies for dynamic hyperpolarized urea imaging. Magn Reson Med. 2026 Mar;95(3):1671-1683. doi: 10.1002/mrm.70117. Epub 2025 Oct 12. PMID: 41077903; PMCID: PMC12746374.

Msherghi A, Glue-Monroe M, W Eldaya R, Pirhoushiaran M, Al Qudah H, Taslicay CA, Alizada S, Salim HA, Y Ballester L, Wintermark M. Preliminary assessment of an MRI-based grading system for leptomeningeal disease: an exploratory prognostic framework. Neuroradiology. 2026 Jan 26. doi: 10.1007/s00234-026-03904-1. Epub ahead of print. PMID: 41582099.

Msherghi A, Wong F, Xu G, Mawlawi O, Elhadi M, Alsharedi M, Salim HA, Alizada S, Ray WJ, Puduvalli VK, Wintermark M. 18F-FDG PET Reveals Voxel-Based Decreases in Brain Glucose Uptake After Chemotherapy in Leukemia Patients: A Retrospective Matched-Control Study. J Nucl Med. 2025 Dec 3;66(12):1883-1890. doi: 10.2967/jnumed.125.270661. PMID: 41101978.

Muir MT, Noll K, Patel R, Prinsloo S, Michener H, Kumar VA, Ene C, Ferguson S, Weinberg JS, Lang F, Taylor BA, Prabhu SS. Toward data-driven surgical planning: multimodal mapping correlates of aphasic surgical deficits. J Neurosurg. 2025 Oct 24;144(2):324-335. doi: 10.3171/2025.6.JNS242301. PMID: 41135113.

Muir MT, Noll K, Prinsloo S, Michener H, Traylor JI, Kumar VA, Ene CI, Ferguson S, Liu HL, Weinberg JS, Lang F, Taylor BA, Forkel SJ, Prabhu SS. Preoperative Brain Mapping Predicts Language Outcomes After Eloquent Tumor Resection. Hum Brain Mapp. 2025 Oct 15;46(15):e70340. doi: 10.1002/hbm.70340. PMID: 41099461; PMCID: PMC12529647.

Muir MT, Noll K, Traylor JI, Patel R, Kumar VA, Prabhu SS, Hou P, Liu HL, Stafford RJ, Taylor BA. Resectability of White Matter Tracts in Patients With Language-Critical Gliomas. Neurosurgery. 2025 Oct 15. doi: 10.1227/neu.0000000000003792. Epub ahead of print. PMID: 41090910.

Noll KR, Bander ED, Chen HS, Bradshaw M, Wefel JS, Kumar VA, Prabhu SS, Liu HL. Changes in functional connectivity are associated with functional independence in the early postoperative period following awake surgical resection of language-eloquent glioma. Neurooncol Adv. 2025 Sep 2;7(1):vdaf192. doi: 10.1093/noajnl/vdaf192. PMID: 41019665; PMCID: PMC12461250.

Pirhoushiaran M, Walker-Charles K, Yao TH, Putluri S, Patel N, Wang DH, Wang I, Arjuna S, Dono A, Bueno A, Nguyen S, Balar AP, Huse JT, Kundu S, Esquenazi Y, Patel CB, Prabhu SS, Lang FF, Ballester LY. Exploring CSF microRNA signatures as diagnostic biomarkers in adult-type diffuse gliomas. Noncoding RNA Res. 2026 Jan 17;18:22-38. doi: 10.1016/j.ncrna.2025.12.003. PMID: 41624475; PMCID: PMC12854873.

Punwani S, Larson PEZ, Laustsen C, VanderMeulen J, Ardenkjær-Larsen JH, Autry AW, Bankson JA, Bernard J, Bok R, Bertelsen LB, Che J, Chen AP, Chowdhury R, Comment A, Cunningham CH, Dang D, Gallagher FA, Gaunt A, Gong Y, Gordon JW, Grimmer A, Grist J, Hansen ESS, Lerche MH, Hesketh RL, Hoevener JB, Hsieh CY, Keshari KR, Kozerke S, Lanz T, Mayer D, McLean M, Park JM, Slater J, Tyler D, Vanderheyden JL, von Morze C, Zaccagna F, Zaha V, Xu D, Vigneron D; HP 13C MRI Consensus Group. Consensus recommendations for hyperpolarized [1-13C]pyruvate MRI multi-center human studies. Magn Reson Med. 2025 Oct;94(4):1386-1400. doi: 10.1002/mrm.30570. Epub 2025 Jun 16. PMID: 40523079; PMCID: PMC12236423.

Salim HA, Msherghi A, Learned K, Zafereo M, Wang J, Dagher SA, Altintas Taslicay C, Dagher R, Alizada S, Hu MI, Cabanillas ME, Busaidy N, Hamidi S, Tawbi H, Li J, Ucisik FE, Wintermark M. Prognostic Factors in Thyroid Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis. Thyroid. 2025 Dec;35(12):1378-1390. doi: 10.1177/10507256251372639. Epub 2025 Sep 4. PMID: 40956665.

Semmineh NB, Guha I, Healey D, Chandrasekharan A, Quarles CC, Boxerman JL. Imaging Intravoxel Vessel Size Distribution in the Brain Using Susceptibility Contrast Enhanced MRI. Imaging Neuroscience. 2025 Mar 25:arXiv:2503.17600v2. PMID: 40196141; PMCID: PMC11975306.

Teo JM, Kumar VA, Khalaf AM, Noll KR, Ferguson SD, Ene CI, Prabhu SS, Wintermark M, Liu HL. Probabilistic template matching for detecting resting-state functional MRI language network in brain tumor patients. Med Phys. 2025 Nov;52(11):e70138. doi: 10.1002/mp.70138. PMID: 41231662; PMCID: PMC12614290.

Tran HH, Yamaguchi A, Manning HC. Radiotheranostic landscape: A review of clinical and preclinical development. Eur J Nucl Med Mol Imaging. 2025 Jun;52(7):2685-2709. doi: 10.1007/s00259-025-07103-7. Epub 2025 Feb 1. PMID: 39891713.

Vachha BA, Kumar VA, Pillai JJ, Shimony JS, Tanabe J, Sair HI. Resting-State Functional MRI: Current State, Controversies, Limitations, and Future Directions-AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2025 Sep;225(3):e2432163. doi: 10.2214/AJR.24.32163. Epub 2024 Dec 11. PMID: 39660823.